Results 201 to 210 of about 13,220 (219)

Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections: Table 1.

Clinical Infectious Diseases, 2016
Ryan K Shields, Ghady Haidar, Yohei Doi
exaly  

Ceftazidime-avibactam Versus Doripenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: RECAPTURE, a Phase 3 Randomized Trial Program

Clinical Infectious Diseases, 2016
Jack D Sobel
exaly  

Ceftazidime Avibactam

Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee   +2 more
openaire   +1 more source

Identifying Spectra of Activity and Therapeutic Niches for Ceftazidime-Avibactam and Imipenem-Relebactam against Carbapenem-Resistant Enterobacteriaceae

Antimicrobial Agents and Chemotherapy, 2017
Ghady Haidar, Cornelius J Clancy, Liang Chen   +2 more
exaly  

Ceftazidime-Avibactam and Aztreonam, an Interesting Strategy To Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae and Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy, 2017
Benjamin Davido, Martin Rottman
exaly  

Ceftazidime and ceftazidime/avibactam

Endimiani, Andrea, Wright, Hugh
openaire   +1 more source

Pharmacotherapy Review of Ceftazidime-Avibactam.

South Dakota medicine : the journal of the South Dakota State Medical Association, 2017
Amber, Yaeger, John, Kappes
openaire   +1 more source

Ceftazidime/avibactam against drug-resistant Enterobacteriaceae

PharmacoEconomics & Outcomes News, 2019
openaire   +1 more source

Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

Clinical Microbiology and Infection, 2020
exaly  

Resistance to Ceftazidime-Avibactam Is Due to Transposition of KPC in a Porin-Deficient Strain of Klebsiella pneumoniae with Increased Efflux Activity

Antimicrobial Agents and Chemotherapy, 2017
Peera Hemarajata, Shangxin Yang, Robert Sebra   +2 more
exaly